Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P840064/S089

VISCOAT Ophthalmic Viscosurgical Device

Alcon Laboratories · Decision date Feb 10, 2026

FDA DECISIONP840064/S089

What did the FDA approve?

FDA records P840064/S089 as a supplement to PMA P840064, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Feb 10, 2026.

FDA approval order statement

approval for adding a new fill volume (0.75 mL) of an ophthalmic viscosurgical device (OVD) into a 1 mL syringe. This would be produced at the LifeCore Biomedical site.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Ophthalmic
Decision date
Feb 10, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P840064/S089
Regulatory pathway
PMA supplement
Product code
LZP
Decision code
APPR
Decision date
Feb 10, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: AID, SURGICAL, VISCOELASTIC.

Product code
LZP
FDA device class
3

For the original device and its historical approval scope, see PMA P840064. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P840064 · Original PMA

    VISCOAT(TM)/DVOVISC/DISCOVISC OPHTHALMIC VISCOSURGICAL DEVICES

  2. P840064/S089 received

    Application receipt date recorded by FDA.

  3. P840064/S090 · Related supplement

    VISCOAT Ophthalmic Viscosurgical Device, DISCOVISC Ophthalmic Viscosurgical Device

  4. P840064/S091 · Related supplement

    VISCOAT Ophthalmic Viscosurgical Device; DUOVISC Ophthalmic Viscoelastic System; DISCOVISC Ophthalmic Viscosurgical D

  5. P840064/S089 · FDA decision

    Normal 180 Day Track

  6. P840064/S092 · Related supplement

    VISCOAT Ophthalmic Viscosurgical Device; DUOVISC Ophthalmic Viscoelastic System.

  7. P840064/S094 · Related supplement

    VISCOAT Ophthalmic Viscosurgical Device; DUOVISC Ophthalmic Viscosurgical System; DISCOVISC Ophthalmic Viscosurgical

Timeline entries are records held by MedtechLedger for P840064. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P840064

Explore the linked device profile

Other records with product code LZP

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Alcon Laboratories

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
6201 S. Fwy., Fort Worth, TX, 76134

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records